OGN

시간 외 거래: 9.22

오가논 & Co (OGN)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 배당 이력

Relative Volume:

오가논 & Co Stock (OGN) Company Profile

Healthcare (1163)

551-430-6000

30 HUDSON STREET, JERSEY CITY

최신 SEC 제출 서류

OGN's Discussions on Twitter

OGN을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
OGN Organon Co	9.22	2.27B	6.29B	750.00M	586.00M	2.88
LLY Lilly Eli Co	625.65	670.04B	53.26B	13.80B	-50.20M	15.30
JNJ Johnson Johnson	173.33	410.84B	90.63B	22.66B	16.40B	9.35
ABBV Abbvie Inc	198.05	346.78B	58.33B	3.76B	18.24B	2.10
NVS Novartis Ag Adr	116.84	219.72B	55.19B	13.65B	16.81B	6.86
MRK Merck Co Inc	80.69	198.42B	63.62B	16.41B	14.72B	6.49

오가논 & Co Stock (OGN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-05-02	다운그레이드	Evercore ISI	Outperform → In-line
2024-09-06	다운그레이드	JP Morgan	Neutral → Underweight
2023-11-03	다운그레이드	Goldman	Buy → Neutral
2023-09-21	개시	Barclays	Overweight
2023-03-16	개시	Raymond James	Outperform
2022-10-14	다운그레이드	BofA Securities	Neutral → Underperform
2022-09-06	업그레이드	Piper Sandler	Neutral → Overweight
2022-08-05	다운그레이드	BofA Securities	Buy → Neutral
2022-04-27	개시	Goldman	Buy
2022-04-06	재개	Morgan Stanley	Equal-Weight
2021-10-07	개시	Piper Sandler	Neutral
2021-09-01	개시	BofA Securities	Buy
2021-07-22	개시	Citigroup	Buy
2021-06-15	개시	JP Morgan	Neutral
2021-06-11	개시	Morgan Stanley	Equal-Weight
2021-06-10	개시	Evercore ISI	Outperform

오가논 & Co 주식(OGN)의 최신 뉴스

오가논 & Co (OGN) 재무 분석

오가논 & Co (OGN)

오가논 & Co Stock (OGN) Company Profile

OGN을(를) 다른 주식과 비교

오가논 & Co Stock (OGN) Upgrades & Downgrades

오가논 & Co 주식(OGN)의 최신 뉴스

Organon & Co. (OGN): Assessing Dividend Sustainability and Valuation Amid Earnings Pressures and Strategic Catalysts - AInvest

Read This Before Considering Organon & Co. (NYSE:OGN) For Its Upcoming US$0.02 Dividend - sg.finance.yahoo.com

Organon & Co. (OGN) Reports Q2 2025 Results - MSN

Organon Q2 Preview: What to expect? - MSN

Organon & Co. (NYSE:OGN) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Organon & Co. (NYSE:OGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year - Yahoo Finance

Organon & Co. Earnings Call: Resilience Amid Challenges - The Globe and Mail

Organon (OGN) Fiscal Q2 Revenue Beats 1% - AOL.com

Organon & Co. (OGN) Slashes 13.13% on Disappointing Earnings - MSN

Organon Q2 Earnings: It May Be Time To Desert This Sinking Ship (Downgrade) (NYSE:OGN) - Seeking Alpha

Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail

Organon & Co. SEC 10-Q Report - TradingView

Organon & Co. (NYSE:OGN) Q2 2025 Earnings Call Transcript - Insider Monkey

Organon Reports Results for the Second Quarter Ended June 30, 2025 - BioSpace

Organon & Co (OGN) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth By GuruFocus - Investing.com Canada

Organon & Co. Reports Q2 2025 Financial Results - TipRanks

Organon: Q2 Earnings Snapshot - Norwalk Hour

Organon raises 2025 revenue guidance by $100M amid Vtama ramp and debt reduction focus - MSN

Organon & Co To Go Ex-Dividend On August 15th, 2025 With 0.02 USD Dividend Per Share - 富途牛牛

Organon reports Q2 adjusted EPS $1.00, consensus 94c - TipRanks

Organon raises FY25 revenue view to $6.28B-$6.38B from $6.13B-$6.33B - TipRanks

OGN Shares Plunge: Lawsuit Drives Market Shock - StocksToTrade

Organon & Co. 2025 Q2ResultsEarnings Call Presentation (NYSE:OGN) - Seeking Alpha

Earnings call transcript: Organon Q2 2025 beats EPS expectations, stock volatile - Investing.com

Organon Becomes Oversold - Nasdaq

Organon (OGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Organon & Co. Reports Strong Q2 Earnings, Surpassing ExpectationsNews and Statistics - IndexBox

Organon surpasses expectations with $1.59B revenue in Q2 2025 - grafa.com

Organon's Strategic Path to Financial Stability and Dividend Resumption - AInvest

Organon Q2 2025 slides: Revenue guidance raised amid Women’s Health strength - Investing.com Australia

Organon (OGN) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Organon jumps despite Q2 revenue dip as revised outlook exceeds consensus - MSN

Organon Q2 Adjusted Earnings, Revenue Fall, Beat Estimates; 2025 Revenue Guidance Raised - MarketScreener

Organon stock jumps after Q2 revenue beat (OGN:NYSE) - Seeking Alpha

Organon (NYSE:OGN) Surprises With Q2 Sales, Stock Soars - Yahoo Finance

Organon shares surge over 8% as Q2 earnings top estimates, raises revenue outlook - Investing.com India

Organon Co earnings beat by $0.06, revenue topped estimates - Investing.com Australia

Earnings Snapshot: Organon new revenue outlook beats estimates after strong Q2 (OGN:NYSE) - Seeking Alpha

Organon in charts: Women's Health revenue up ~3% Y/Y in Q2 (NYSE:OGN) - Seeking Alpha

Organon Earnings: What To Look For From OGN - Yahoo Finance

Organon & Co. (OGN) Expected to Announce Earnings on Tuesday - Defense World

Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics - Yahoo Finance

Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

OGN’s Market Whiplash: -54.75% YTD Decline, 3.72% Rise in 30 Days - investchronicle.com

Organon adds mood tracking to Propecia app in Korea, with global rollout ahead - koreabiomed.com

Organon & Co (OGN.US) will release its Earnings Reports before the market opens on August 5th. - 富途牛牛

Can Analyst Optimism Outweigh Softer Earnings Expectations for Organon (OGN) This Quarter? - simplywall.st

Ramsay Health Care (OTCMKTS:RMYHY) vs. Organon & Co. (NYSE:OGN) Head to Head Contrast - Defense World

Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy? - MSN

Envestnet Asset Management Inc. Has $4.51 Million Holdings in Organon & Co. (NYSE:OGN) - Defense World

오가논 & Co (OGN) 재무 분석

매출

순이익

현금흐름

주당 순 이익

OGN과 유사한 종목